LYKALABS Share Price Target 2035

CAGR-based price projection for Lyka Labs Limited (LYKALABS) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (11.6% CAGR)
Rs 200
2035 Target
Base Case (28.9% CAGR)
Rs 735
2035 Target
Bull Case (86.0% CAGR)
Rs 19,956
2035 Target

Current Market Snapshot

CMP: Rs 74.83
52W High: Rs 74.83
52W Low: Rs 56.53
1Y CAGR: 66.2%
3Y CAGR: 28.9%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 83 Rs 96 Rs 139
2028 Rs 93 Rs 124 Rs 259
2029 Rs 104 Rs 160 Rs 482
2030 Rs 116 Rs 207 Rs 896
2031 Rs 129 Rs 266 Rs 1,667
2032 Rs 144 Rs 343 Rs 3,100
2033 Rs 161 Rs 443 Rs 5,767
2034 Rs 180 Rs 571 Rs 10,728
2035 Rs 200 Rs 735 Rs 19,956

Other LYKALABS Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the LYKALABS share price target for 2035?

Based on historical growth analysis, the LYKALABS share price target for 2035 ranges from Rs 200 (conservative) to Rs 735 (base case) to Rs 19,956 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of LYKALABS?

The current market price of LYKALABS (Lyka Labs Limited) is Rs 74.83. The 52-week high is Rs 74.83 and 52-week low is Rs 56.53.

Is LYKALABS a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for LYKALABS price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 11.6% CAGR), Base (28.9% CAGR), and Bull (optimistic at 86.0% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.